Keratinocyte growth factor-induced hyperplasia of rat alveolar type II cells in vivo is resolved by differentiation into type I cells and by apoptosis

European Respiratory Journal

Volumn 14, Issue 3, 1999, Pages 534-544

  Fehrenbach, H ^c   Kasper, M ^d   Tschernig, T ^a   Pan, T ^b   Schuh, D ^d   Shannon, J M ^b   Muller M ^d   Masor, R J ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d NONE

Author keywords

Alveolar epithelium; Apoptosis; Differentiation; Hyperplasia; Keratinocyte growth factor; Type II cell

Indexed keywords

CAVEOLIN; CYTOKERATIN 18; HERMES ANTIGEN; KERATINOCYTE GROWTH FACTOR; KI 67 ANTIGEN; RECOMBINANT KERATINOCYTE GROWTH FACTOR; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL HYPERPLASIA; DRUG MECHANISM; GROWTH STIMULATION; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INTRATRACHEAL DRUG ADMINISTRATION; LUNG ALVEOLUS CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, CD44; APOPTOSIS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; EPITHELIAL CELLS; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCOPROTEINS; GROWTH SUBSTANCES; HYPERPLASIA; IN SITU NICK-END LABELING; KI-67 ANTIGEN; PULMONARY ALVEOLI; PULMONARY SURFACTANTS; RATS; RATS, INBRED F344; RECOMBINANT PROTEINS;

EID: 0032869682     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.14c10.x     Document Type: Article

References (46)

1. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989; 245: 752-755.
2. Aaronson SA, Bottaro DP, Miki T, et al. Keratinocyte growth factor. A fibroblast growth factor family member with unusual target cell specificity. Ann N Y Acad Sci 1991; 638: 62-77.
3. Rubin JS, Bottaro DP, Chedid M, et al. Keratinocyte growth factor. Cell Biol Int 1995; 19: 399-411.
4. Werner S. Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev 1998; 9: 153-165.
5. Panos RJ, Rubin JS, Csaky KG, Aaronson SA, Mason RJ. Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J Clin Invest 1993; 92: 969-977.
6. Adamson IY, Young L, Bakowska J. Enhanced alveolar type II cell growth on a pulmonary extracellular matrix over fibroblasts. Am J Physiol 1997; 272: L413-L417.
7. Sugahara K, Rubin JS, Mason RJ, Aronsen EL, Shannon JM. Keratinocyte growth factor increases mRNAs for SP-A and SP-B in adult rat alveolar type II cells in culture. Am J Physiol 1995; 269: L344-L350.
8. Ulich TR, Yi ES, Longmuir K, et al. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J Clin Invest 1994; 93: 562-572.
9. Guo J, Yi ES, Havill AM, et al. Intravenous keratinocyte growth factor protects against experimental pulmonary injury. Am J Physiol 1998; 275: L800-L805.
10. Yano T, Deterding RR, Simonet WS, Shannon JM, Mason RJ. Keratinocyte growth factor reduces lung damage due to acid instillation in rats. Am J Respir Cell Mol Biol 1996; 15: 433-442.
11. Mason CM, Guery BP, Summer WR, Nelson S. Keratinocyte growth factor attenuates lung leak induced by alpha-naphthylthiourea in rats. Crit Care Med 1996; 24: 925-931.
12. Yi ES, Williams ST, Lee H, et al. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. Am J Pathol 1996; 149: 1963-1970.
13. Deterding RR, Havill AM, Yano T, et al. Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor. Proc Assoc Am Physicians 1997; 109: 254-268.
14. Yi ES, Salgado M, Williams S, et al. Keratinocyte growth factor decreases pulmonary edema, transforming growth factor-beta and platelet-derived growth factor-BB expression, and alveolar type II cell loss in bleomycin-induced lung injury. Inflammation 1998; 22: 315-325.
15. Kalina M, Mason RJ, Shannon JM. Surfactant protein C is expressed in alveolar type II cells but not in Clara cells of rat lung. Am J Respir Cell Mol Biol 1992; 6: 594-600.
16. Kasper M, Rudolf T, Hahn R, Peterson I, Müller M. Immuno- and lectin histochemistry of epithelial subtypes and their changes in a radiation-induced lung fibrosis model of the mini pig. Histochemistry 1993; 100: 367-377.
17. Kasper M, Albrecht S, Grossmann H, Grosser M, Schuh D, Müller M. Monoclonal antibodies to surfactant protein D: evaluation of immunoreactivity in normal rat lung and in a radiation-induced fibrosis model. Exp Lung Res 1995; 21: 577-588.
18. Kasper M, Singh G. Epithelial lung cell marker: current tools for cell typing. Histol Histopathol 1995; 10: 155-169.
19. Kasper M, Bierhaus A, Whyte A, Binns RM, Schuh D, Müller M. Expression of CD44 isoforms during bleomycin-or radiation-induced pulmonary fibrosis in rats and mini-pigs. Histochem Cell Biol 1996; 105: 221-230.
20. Kasper M, Reimann T, Hempel U, et al. Loss of caveolin expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis. Histochem Cell Biol 1998; 109: 41-48.
21. Gerlach C, Sakkab DY, Scholzen T, Dassler R, Alison MR, Gerdes J. Ki-67 expression during rat liver regeneration after partial hepatectomy. Hepatology 1997; 26: 573-578.
22. Koslowski R, Dobbs LG, Wenzel KW, Schuh D, Müller M, Kasper M. Loss of immunoreactivity for RTI40, a type I cell-specific protein in the alveolar epithelium of rat lungs with bleomycin-induced fibrosis. Eur Respir J 1998; 12: 1397-1403.
23. Fehrenbach H, Ochs M. Studying lung ultrastructure. In: Uhlig S, Taylor AE, Eds. Methods in Pulmonary Research. Basel, Birkhauser Verlag, 1998; 429-454.
24. Nomoto Y, Kuwano K, Hagimoto N, Kunitake R, Kawasaki M, Hara N. Apoptosis and Fas/Fas ligand mRNA expression in acute immune complex alveolitis in mice. Eur Respir J 1997; 10: 2351-2359.
25. Howard CV, Reed MG. Unbiased stereology. Three-dimensional measurement in microscopy. Oxford, BIOS Scientific Publishers, 1998.
26. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 1989; 86: 802-806.
27. Kasper M, Rudolf T, Verhofstad AA, Schuh D, Müller M. Heterogeneity in the immunolocalization of cytokeratin-specific monoclonal antibodies in the rat lung: evaluation of three different alveolar epithelial cell types. Histochemistry 1993; 100:65-71.
28. Bankston PW, Porter GA, Milici AJ, Palade GE. Differential and specific labeling of epithelial and vascular endothelial cells of the rat lung by Lycopersicon esculentum and Griffonia simplicifolia I lectins. Eur J Cell Biol 1991; 54: 187-195.
29. Schittny JC, Djonov V, Fine A, Burri PH. Programmed cell death contributes to postnatal lung development. Am J Respir Cell Mol Biol 1998; 18: 786-793.
30. Pinkerton KE, Gehr P, Crapo JD. Architecture and cellular composition of the air-blood barrier. In: Parent RA, Ed. Comparative Biology of the Normal Lung. Boca Raton, CRC Press, 1992; 121-128.
31. Kasper M, Haroske G. Alterations in the alveolar epithelium after injury leading to pulmonary fibrosis. Histol Histopathol 1996; 11: 463-483.
32. Yu CC, Woods AL, Levison DA. The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem J 1992; 24: 121-131.
33. Fasano M, Sabatini MT, Wieczorek R, Sidhu G, Goswami S, Jagirdar J. CD44 and its v6 spliced variant in lung tumors: a role in histogenesis. Cancer 1997; 80: 34-41.
34. Günthert U, Hofmann M, Rudy W, et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
35. Weber GF, Ashkar S, Cantor H. Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proc Assoc Am Physicians 1997; 109: 1-9.
36. Svee K, White J, Vaillant P, et al. Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest 1996; 98: 1713-1727.
37. Crouch E. Pathobiology of pulmonary fibrosis. Am J Physiol 1990; 259: L159-L184.
38. Kasper M, Günthert U, Dall P, et al. Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis. Am J Respir Cell Mol Biol 1995; 13: 648-656.
39. Woodcock-Mitchell J, Mitchell JJ, Reynolds SE, Leslie KO, Low RB. Alveolar epithelial cell keratin expression during lung development. Am J Respir Cell Mol Biol 1990; 2: 503-514.
40. Paine R, Ben-Ze'ev A, Farmer SR, Brody JS. The pattern of cytokeratin synthesis is a marker of type 2 cell differentiation in adult and maturing fetal lung alveolar cells. Dev Biol 1988; 129: 505-515.
41. Borok Z, Lubman RL, Danto SI, et al. Keratinocyte growth factor modulates alveolar epithelial cell phenotype in vitro: expression of aquaporin 5. Am J Respir Cell Mol Biol 1998; 18: 554-561.
42. Simonet WS, DeRose ML, Bucay N, et al. Pulmonary malformation in transgenic mice expressing human keratinocyte growth factor in the lung. Proc Natl Acad Sci USA 1995; 92: 12461-12465.
43. Shiratori M, Oshika E, Ung LP, et al. Keratinocyte growth factor and embryonic rat lung morphogenesis. Am J Respir Cell Mol Biol 1996; 15: 328-338.
44. Bardales RH, Xie SS, Schaefer RF, Hsu SM. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 1996; 149: 845-852.
45. Verghese GM, McCormick-Shannon K, Mason RJ, Matthay MA. Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance. Am J Respir Crit Care Med 1998; 158: 386-394.
46. Stern J-B, Paugam C, Fierobe L, et al. Presence of keratinocyte growth factor (KGF) and hepatocyte growth factor (HGF) in BAL fluid of mechanically ventilated patients with or without ARDS. Am J Respir Crit Care Med 1999; 159: A694 [abstract].